4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001100682-26-000033
EVP & Chief Financial Officer acquired 21,112 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Glenn EVP & Chief Financial Officer | 2026-05-01 | Grant or award | +21,112 | $165.78 | $3,499,947 | 21,112 | D: show line 1 in the form |
Loading xslF345X06/form4.xml…